Trial Profile
A multicenter study to assess the cholesterol lowering level of switching to an investigational drug compared to doubling the dose of an investigational drug in patients with hypercholesterolemia and atherosclerotic or coronary vascular disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Atorvastatin
- Indications Atherosclerosis; Coronary disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Organon
- 22 Oct 2005 New trial record.